𝛼SK or Search

ENTITY

Zhejiang Starry Pharmaceutical (603520 CH)

5

Analysis

Health Care • China

Zhejiang Starry Pharmaceutical Company Ltd. manufactures medical drugs. The Company specializes in the production of pharmaceutical raw materials and intermediates for the production of fluoroquinolones.

more

Refresh

Exchange Announcement • 07 Sep 2026 08:00

Announcement on Implementation of Dividend Distribution for the First Half of 2026

Exchange Announcement • 31 Aug 2026 08:00

Announcement on Resolutions of the 2nd Meeting of the 6th Board of Directors

Exchange Announcement • 31 Aug 2026 08:00

Full Text of the Semi-annual Report for 2026

Exchange Announcement • 31 Aug 2026 08:00

Announcement on the Interim Profit Distribution Proposal for 2026

Exchange Announcement • 14 Aug 2026 08:00

Announcement on Results of Shareholding Reduction by the Actual Controller and Completion of Internal Share Transfer Among Persons Acting in Concert

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x